ESMO 2012 News

Welcome to ESMO 2012 news. Here you will find a selection of articles that appeared in the ESMO 2012 newspaper, Congress Daily, which was distributed to attendees of the ESMO congress in Vienna.

Complete copies of the four newspapers are available for download as PDF files

Filter

Date Title Topic
02 Oct 2012 ESMO 2012 - breaks all records
02 Oct 2012 Data fails to support routine use of doxorubicin and ifosfamide combination for soft tissue sarcoma Sarcomas
02 Oct 2012 Doxorubicin remains the gold standard in the first line chemotherapy for patients with advanced or metastatic soft tissue sarcoma Sarcomas
02 Oct 2012 ESMO 2012 emphasises palliative care Palliative and supportive care
02 Oct 2012 Antivirals and chemotherapy: Managing cancer patients with hepatitis Gastrointestinal cancers
02 Oct 2012 Final results of the TEMAVIR ANOCEF study in patients with unresectable glioblastoma Central nervous system malignancies
02 Oct 2012 Gastric cancer – a heterogeneous disease in need of a refined approach Gastrointestinal cancers
02 Oct 2012 Is there an opportunity for personalised medicine in HCC? Gastrointestinal cancers
02 Oct 2012 Maintenance treatment with MGN1703 following standard first-line treatment prolongs progression-free survival in patients with metastatic colorectal cancer Gastrointestinal cancers
02 Oct 2012 Managing the costs of emerging oncology therapies Bioethics, legal and economic issues
02 Oct 2012 Meeting the challenges of clinical trial design in cancer Anticancer agents & Biologic therapy
02 Oct 2012 No gain from adding cetuximab to FOLFOX4 in patients with resected stage III colon cancer Gastrointestinal cancers
02 Oct 2012 Patients with advanced hepatocellular carcinoma show no benefit from adding erlotinib to sorafenib Gastrointestinal cancers
02 Oct 2012 Step into the future Gastrointestinal cancers - Anticancer agents & Biologic therapy
02 Oct 2012 Treatment with bevacizumab beyond progression: A new standard in mCRC? Gastrointestinal cancers - Anticancer agents & Biologic therapy